Table 5.
Age-statin use-adjusted mean serum lipid levels among all participants with and without copd and by Hispanic/Latino heritage groups.
| Estimate (95% Confidence Interval) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Parameter | Total Population (N=14012) |
Mexican (n=5651) |
Cuban (n=2116) |
Puerto Rican (n=2204) |
Dominican (n=1178) |
Central American (n=1502) |
South American (n=941) |
Other (N=420) |
| TC (mg/dL) | ||||||||
| COPD: Yes | 191.3 (181.7–201.0) | 198.8 (181.9215.6) | 195.2 (184.0206.4) | 183.9 (172.8195.0) | 177.9 (158.5197.2) | 197.6 (185.1–210.1) | 201.5 (178.6–224.5) | 181.4 (160.7202.0) |
| COPD: No | 193.8 (192.7–194.8) | 195.1 (193.4196.8) | 196.2 (194.1198.3) | 185.6 (183.1188.1) | 189.7 (186.5192.9) | 199.5 (196.7–202.3) | 197.4 (194.4–200.4) | 193 (187.6198.3) |
| HDL-C (mg/dL) | ||||||||
| COPD: Yes | 46.5 (44.1–48.8) | 47.7 (43.851.5) | 45.8 (42.748.9) | 46.4 (43.2–49.5) | 44.9 (41.2–48.6) | 49.8 (41.9–57.8) | 47.6 (37.7–57.6) | 37.8 (31.5–44.2) |
| COPD: No | 48.9 (48.5–49.2) | 48.8 (48.249.3) | 48.0 (47.448.6) | 48.2 (47.4–49.1) | 50.8 (49.7–51.9) | 48.5 (47.7–49.3) | 49.8 (48.8–50.8) | 51.0 (49.1–52.9) |
| LDL-C (mg/dL) | ||||||||
| COPD: Yes | 119.9 (111.8–127.9) | 125.1 (111.8138.3) | 122.6 (112.6132.6) | 114.8 (104.5125.1) | 111.9 (94.6129.2) | 117.1 (106.9–127.3) | 131.4 (109.7–153.0) | 114.4 (94.8134.0) |
| COPD: No | 120.1 (119.1–121.0) | 120.3 (118.8121.8) | 123 (121.1124.9) | 114.2 (112.0116.5) | 118.2 (115.3121.2) | 124.2 (121.7–126.8) | 122.2 (119.7–124.8) | 118.1 (113.2123.0) |
| TGs (mg/dL) | ||||||||
| COPD: Yes | 124.5 (113.2–135.8) | 129.6 (115.9143.3) | 133.8 (115.8151.9) | 113.3 (98.6–127.9) | 105.3 (84.8125.7) | 153.5 (115.4–191.6) | 112.1 (88.0–136.3) | 144.9 (98.3191.4) |
| COPD: No | 124.2 (122.5–125.9) | 130 (126.9133.2) | 126.1 (122.7129.5) | 115.6 (112.1119.0) | 103.7 (99.6107.8) | 133.9 (129.7–138.0) | 126.8 (121.6–132.0) | 119.6 (110.9128.3) |